Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2025-12-24 @ 10:30 PM
NCT ID:
NCT07188935
Eligibility Criteria:
Inclusion Criteria:
* Patients age \>18 years, both sex
* Patient with known history of T2DM at least 1 year
* Patients diagnosed with rUTI according to the positive GUE as in practice guideline
* Patients with different glycemic status according to the HbA1c level, and on different treatment for T2DM accordingly.
* Patients with non-diabetic rUTI as active comparator.
* Patients who had the ability to communicate to answer study questionnaire.
Exclusion criteria:
* Type 1 diabetic patients on insulin therapy were excluded.
* T2DM Patients who were using Sodium-glucose co-transporter-2 inhibitors (SGLT-2) (because of their renal -related side effect).
* Patients who received any antimicrobial treatment within the last 72 hours of their enrollment.
* Women patients with recurrent vaginitis or urinary incontinence.
* Men patients with BPH or over flow incontinence ( as a cause for r UTI).
* Patients with chronic disease other than T2DM that may cause rUTI ( eg. CKD, Spinal cord injury. kidney stone).
* Pregnancy and lactation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07188935
Study Brief:
Protocol Section:
NCT07188935